Phenotypes associated with this allele
Allelic Composition |
Rrastm1Itl/Rrastm1Itl
|
|
Genetic Background |
either: (involves: 129S6/SvEvTac) or (involves: 129S6/SvEvTac * C57BL/6) |
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Rrastm1Itl mutation
(0 available);
any
Rras mutation
(19 available)
|
|
|
immune system
N |
• mice exhibit normal T cell development in the thymus and in CD11c+, B220+, CD8+, or CD4+ cells in the spleen
|
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Rrastm1Itl mutation
(0 available);
any
Rras mutation
(19 available)
|
|
|
immune system
|
• LPS-induced dendritic cell maturation is impaired compared with wild-type cells
|
|
• when splenic antibody-presenting cells are co-cultured with allogenic T cell, proliferation of T cells is reduced compared to when wild-type cells are used
• LPS-activated splenic dendritic cells stimulates less T cell proliferation than wild-type cells
• splenic dendritic cells from mice injected with LPS of ovalbumin are less effective in priming a T cell response compared with cells from wild-type mice
• dendritic cells exhibit impaired cell spreading and T cell synapse formation compared with wild-type cells
|
neoplasm
|
• mice injected with B16-F10 mouse melanoma cells exhibit increased tumor incidence (100% versus 14% by 2 weeks) and increased tumor volume (5-fold by 3 weeks) compared with wild-type mice
|
hematopoietic system
|
• LPS-induced dendritic cell maturation is impaired compared with wild-type cells
|
Allelic Composition |
Rrastm1Itl/Rras+
|
|
Genetic Background |
involves: 129S6/SvEvTac * C57BL/6 |
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Rrastm1Itl mutation
(0 available);
any
Rras mutation
(19 available)
|
|
|
neoplasm
|
• mice injected with B16-F10 mouse melanoma cells exhibit increased tumor incidence (78% versus 14% by 2 weeks) and increased tumor volume (2-fold by 3 weeks) compared with wild-type mice
|